secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pelthos Therapeutics Inc. (PTHS)
CIK:        0001919246
Form:       8-K
Filed at:   2026-10-30T13:17:39+00:00
Accession:  0001104659-26-120457
Event type: m_and_a
Sentiment:  positive
Materiality: 0.85
Item codes: 1.01, 2.03, 3.02, 3.03, 5.03, 5.02, 5.07, 7.01, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Pelthos to merge with Castle Creek in stock deal; up to $300M D-Fi milestones plus $57.5M PIPE
--------------------------------------------------------------------------------

- Pelthos to issue 5.2M shares to Castle Creek stockholders, who are expected to own ~32.5% of Pelthos fully diluted pre-PIPE, excluding contingent shares.
- Milestones: $50M on D-Fi clinical milestone by 6/30/2029; $50M on first U.S. sale; $50M at $100M TTM sales; $75M at $250M; $75M at $500M.
- Up to 5.8M contingent shares if FDA approves D-Fi by 3/31/2036 (cut 5%/quarter after 3/31/2031); 80% of PRV proceeds; 10% escrow.
- PIPE: 57,500 Series B preferred at $1,000 stated value plus 496,951 warrants for ~$57.5M; option buyer can add up to $26.6M; max $80M.
- Ligand and holders of ~56.2% voting power approved share issuances by written consent; board grows from 8 to 10 with two Castle Creek designees.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1919246/000110465926120457/0001104659-26-120457-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1919246/000110465926120457/tm2628523d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-120457

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer